BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 3132336)

  • 1. Ehrlich ascites tumour cells become refractory to alpha-difluoromethylornithine at a certain stage of growth.
    Anehus S; Oredsson SM; Heby O
    Cell Biochem Funct; 1988 Apr; 6(2):115-21. PubMed ID: 3132336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of ornithine decarboxylase activity and cell growth by diamines: a comparison between the effects of two homologs, 1,3-diaminopropane and 1,4-diaminobutane (putrescine).
    Linden M; Oredsson SM; Anehus S; Heby O
    J Cell Biochem; 1985; 29(2):105-13. PubMed ID: 3934184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polyamine depletion and growth inhibition in Candida albicans and Candida tropicalis by alpha-difluoromethylornithine and cyclohexylamine.
    Pfaller MA; Riley J; Gerarden T
    J Med Vet Mycol; 1988 Apr; 26(2):119-26. PubMed ID: 3138402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor necrosis factor stimulates ornithine decarboxylase activity in human fibroblasts and tumor target cells.
    Donato NJ; Rotbein J; Rosenblum MG
    J Cell Biochem; 1991 May; 46(1):69-77. PubMed ID: 1874802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of inhibition of polyamine biosynthesis by DL-alpha-difluoromethylornithine on the growth and melanogenesis of B16 melanoma in vitro and in vivo.
    Sunkara PS; Chang CC; Prakash NJ; Lachmann PJ
    Cancer Res; 1985 Sep; 45(9):4067-70. PubMed ID: 3928149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-IgM-induced growth inhibition and apoptosis are independent of ornithine decarboxylase in Ramos cells.
    Lin CK; Zou HY; Kaptein JS; Yen CF; Kalunta CI; Nguyen TT; Park E; Lad PM
    Exp Cell Res; 1997 Nov; 237(1):231-41. PubMed ID: 9417887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of treatments with alpha-difluoromethylornithine and hyperthermia on the growth and polyamine metabolism of Harding-Passey murine melanoma.
    Lopez Ballester JA; Peñafiel R; Cremades A; Valcarcel MM; Solano F; Lozano JA
    Anticancer Res; 1991; 11(2):691-6. PubMed ID: 1905904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of ornithine decarboxylase potentiates nitric oxide production in LPS-activated J774 cells.
    Baydoun AR; Morgan DM
    Br J Pharmacol; 1998 Dec; 125(7):1511-6. PubMed ID: 9884080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Difluoromethylornithine and ethylglyoxal bis(guanylhydrazone) as inhibitors of human renal carcinoma cell proliferation and polyamine metabolism.
    Sjöholm A; Larsson R; Nygren P
    Anticancer Res; 1993; 13(4):979-83. PubMed ID: 8352568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Revival of 2-(difluoromethyl)ornithine (DFMO), an inhibitor of polyamine biosynthesis, as a cancer chemopreventive agent.
    Raul F
    Biochem Soc Trans; 2007 Apr; 35(Pt 2):353-5. PubMed ID: 17371277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ornithine decarboxylase and extracellular polyamines regulate microvascular sprouting and actin cytoskeleton dynamics in endothelial cells.
    Kucharzewska P; Welch JE; Svensson KJ; Belting M
    Exp Cell Res; 2010 Oct; 316(16):2683-91. PubMed ID: 20594968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antizyme delays the restoration by spermine of growth of polyamine-deficient cells through its negative regulation of polyamine transport.
    He Y; Suzuki T; Kashiwagi K; Igarashi K
    Biochem Biophys Res Commun; 1994 Aug; 203(1):608-14. PubMed ID: 8074711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of alpha-difluoromethylornithine on the cyclin A expression in Hep-2 cells.
    Marty C; Mori G; Sabini L; Rivarola V
    Biocell; 2000 Apr; 24(1):49-52. PubMed ID: 10893799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of alpha-difluoromethyl ornithine as an adjuvant to immunotherapy in mice bearing transplantable tumors.
    Chowdhury SR; Guha S; Sen U
    Neoplasma; 1994; 41(3):159-61. PubMed ID: 7935984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p53 independent G(1) arrest induced by DL-alpha-difluoromethylornithine.
    Nemoto T; Kamei S; Seyama Y; Kubota S
    Biochem Biophys Res Commun; 2001 Jan; 280(3):848-54. PubMed ID: 11162600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of mouse skin tumor promotion and of promoter-stimulated epidermal polyamine biosynthesis by alpha-difluoromethylornithine.
    Takigawa M; Verma AK; Simsiman RC; Boutwell RK
    Cancer Res; 1983 Aug; 43(8):3732-8. PubMed ID: 6407752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of acylated derivatives of ascorbate on ornithine decarboxylase induction in Ehrlich ascites tumor cells.
    Matsui-Yuasa I; Otani S; Morisawa S; Kageyama K; Onoyama Y; Yamazaki H; Miwa N
    Biochem Int; 1989 Mar; 18(3):623-9. PubMed ID: 2764967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resumption of cell cycle in BALB/c-3T3 fibroblasts arrested by polyamine depletion: relation with "competence" gene expression.
    Charollais RH; Mester J
    J Cell Physiol; 1988 Dec; 137(3):559-64. PubMed ID: 3142887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of polyamines in estradiol-induced growth of human breast cancer cells.
    Lima G; Shiu RP
    Cancer Res; 1985 Jun; 45(6):2466-70. PubMed ID: 3921243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of difluoromethylornithine (DFMO) as a chemoprevention agent.
    Meyskens FL; Gerner EW
    Clin Cancer Res; 1999 May; 5(5):945-51. PubMed ID: 10353725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.